Literature DB >> 9349404

The uveoscleral outflow routes.

S F Nilsson1.   

Abstract

As there is no epithelial barrier between the anterior chamber and the ciliary muscle, aqueous humour may freely pass between the ciliary muscle bundles into the supraciliary and suprachoroidal spaces, from which it is drained through the sclera. This uveoscleral outflow of aqueous humour accounts for 40-60% of the total outflow in monkeys, whereas it is considerably less in (3-8%) in cats and rabbits. Direct measurements in human eyes have suggested that less than 15% is drained by the uveoscleral routes. However, indirect calculations have given a value of about 35% in young adults and 3% in elderly persons (> 60 years). Under normal conditions, in monkeys, the uveoscleral outflow is insensitive to changes in the intraocular pressure, but cyclodialysis and experimental uveitis increase the uveoscleral outflow and make it more pressure sensitive. The uveoscleral outflow is decreased by contraction (pilocarpine) and increased by relaxation (atropine) of the ciliary muscle. Thus, changing the tone of the ciliary muscle may redistribute aqueous humour between the conventional and uveoscleral outflow routes. Prostaglandins decrease the intraocular pressure by increasing the uveoscleral outflow. Two mechanisms seem to contribute to this effect: relaxation of the ciliary muscle and changes in extracellular matrix, causing decreased resistance in the uveoscleral outflow routes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349404     DOI: 10.1038/eye.1997.43

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  32 in total

1.  Characterization of uveoscleral outflow in enucleated porcine eyes perfused under constant pressure.

Authors:  Justin A Wagner; Aurélie Edwards; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

Review 2.  [General substance classification and pharmacology of glaucoma].

Authors:  H Thieme; G Renieri; C Schuart
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

3.  Circadian variation of aqueous dynamics in young healthy adults.

Authors:  Arthur J Sit; Cherie B Nau; Jay W McLaren; Douglas H Johnson; David Hodge
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

4.  In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI.

Authors:  Leon C Ho; Ian P Conner; Chi-Wai Do; Seong-Gi Kim; Ed X Wu; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-24       Impact factor: 4.799

5.  The impact of ocular hemodynamics and intracranial pressure on intraocular pressure during acute gravitational changes.

Authors:  Emily S Nelson; Lealem Mulugeta; Andrew Feola; Julia Raykin; Jerry G Myers; Brian C Samuels; C Ross Ethier
Journal:  J Appl Physiol (1985)       Date:  2017-05-11

Review 6.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

Review 7.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

8.  Consequences of Puberty on Efficacy of Intraocular Pressure-Lowering Drugs in Male Dutch-Belted Rabbits.

Authors:  Cassandra L Hays; Kingsley C Okafor; Shan Fan; Robin High; Dhirendra P Singh; Carol B Toris
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

Review 9.  [Suprachoroidal minimally invasive glaucoma surgery : Procedures and clinical outcome].

Authors:  C Erb
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

10.  The primate model for understanding and restoring vision.

Authors:  Serge Picaud; Deniz Dalkara; Katia Marazova; Olivier Goureau; Botond Roska; José-Alain Sahel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.